FDAClass IISeptember 16, 2020

Cephalexin for Oral Suspension recall

Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals…

Why was Cephalexin for Oral Suspension recalled?

Sub-Potent Drug: Out of specification test results for potency (below specification).

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 30310638A, Exp. 02/2022

Product
Cephalexin for Oral Suspension, USP 250 mg per 5 mL, For Reconstitution, For Oral Use Only, Rx Only, 100 mL bottle when mixed, Teva Pharmaceuticals…
Recalling firm
Teva Pharmaceuticals USA
Quantity
38,487 bottles
Distribution
Nationwide in the U.S. and Puerto Rico.
Recall date
September 16, 2020
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls